Two Giants Dominate IHE, Making It Riskier Than It Looks
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Learn why balancing short and long term goals leads to steadier progress and fewer stressful financial decisions.
28,529 articlesAs of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
New market outlook examines what 10,000 XRP could worth by 2028, with base, bull, and bear scenarios. Regulatory clar...
A cybersecurity ETF surged roughly 40% in the last month, signaling a shift in investor sentiment toward AI-enabled d...
A prominent oil strategist argues the Iran war premium is inflating prices, suggesting oil could trade in the $40s if...
Ethereum posts an 8% weekly gain, rebounding from June lows as institutions step back into the market and traders wei...
A private investment strategy disclosed a $100 million Bitcoin buy funded by a stock sale, boosting its BTC reserves ...
Wells Fargo lowers Meta's price target to 765 but preserves a bullish view as Meta reports strong Q1 FY2026 results a...
Ripple secures a key regulatory foothold in Luxembourg, signaling EU-wide expansion. XRP ETFs continue drawing instit...
Lucid’s Gravity starts at $95,000 with a 450-mile range, claiming superiority over high-powered ICE rivals. The compa...
NVIDIA leads the Magnificent 7 in March with a 1.7% gain through Friday, while Apple and Tesla retreat as investors r...
Bitcoin spot ETFs posted a green week after weeks of outflows, while Ethereum ETFs drew stronger inflows, underscorin...
XRP appears to be forming a bottom as it tests a key floor near $1.20 and eyes a breakout above $1.80, with traders w...